| 标题 |
A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1 |
| 网址 | |
| DOI |
10.4143/crt.2020.459
doi
|
| 其它 |
期刊:Cancer Research and Treatment 作者:Cheol-Kyu Park; Hyun-Ju Cho; Yoo-Duk Choi; In-Jae Oh; Young-Chul Kim 出版日期:2021-01-15 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)